We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified August 2007 by Samsung Medical Center.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT00515996
First Posted: August 14, 2007
Last Update Posted: August 14, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Samsung Medical Center
  Purpose
We plan to examine genetic polymorphism of catechol-O-methyltransferase in panic disorder and neurobiological changes of panic disorder patients after 12 weeks of pharmacotherapy with paroxetine. We plan to include 40 panic disorder patients and 40 normal control subjects in this study for 3 years.

Condition
Panic Disorder

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Longitudinal
Time Perspective: Prospective
Official Title: Genetic Abnormalities and Changes of Autonomic Nervous System, Serotonin System, and Neuroendocrine System According to Pharmacotherapy in Panic Disorder

Resource links provided by NLM:


Further study details as provided by Samsung Medical Center:

Estimated Enrollment: 80
Study Start Date: January 2006
Estimated Study Completion Date: December 2008
Groups/Cohorts
Case: 2
paroxetine treatment group vs. normal control group

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Panic disorder

Exclusion Criteria:

  • Other major medical or psychiatric illnesses
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00515996


Locations
Korea, Republic of
Samsung Medical Center Recruiting
Seoul, Korea, Republic of, 135-710
Contact: Tae Geun Kim, BA    82-2-3410-2975    tggo.kim@samsung.com   
Principal Investigator: Bum-Hee Yu, M.D. & Ph.D.         
Sponsors and Collaborators
Samsung Medical Center
Investigators
Principal Investigator: Bum-Hee Yu, M.D. & Ph.D. Samsung Medical Center, Sungkyunkwan University School of Medicine
  More Information

ClinicalTrials.gov Identifier: NCT00515996     History of Changes
Other Study ID Numbers: C-A6-418-2
First Submitted: August 13, 2007
First Posted: August 14, 2007
Last Update Posted: August 14, 2007
Last Verified: August 2007

Keywords provided by Samsung Medical Center:
panic disorder
paroxetine
genetic polymorphism
serotonin

Additional relevant MeSH terms:
Disease
Panic Disorder
Pathologic Processes
Anxiety Disorders
Mental Disorders
Serotonin
Serotonin Receptor Agonists
Serotonin Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs


To Top